Joint Formulary & PAD

Tezacaftor with ivacaftor - Cystic fibrosis

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Not Specified
Associated Icons :
NHSE
SPC
Restrictions / Comments :

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Tezacaftor with ivacaftor
Indication :
Cystic fibrosis
Group Name :
Keywords :
Brand Names Include :
Symkevi
Important Information :
NHSE Specialist Commissioned Services only
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Committee Recommendations (1)

 This drug / device falls under the responsibility of NHS England Specialised Commissioning and should therefore not be prescribed in Primary Care

Other Indications

Below are listed other indications that Tezacaftor with ivacaftor is used to treat.

  • No records returned.